glp-1 drugs manufacturers suppliers distributors 2023-2025 Market Size, Share GLP-1 Medication Effect on Food

Early clinical trial results, presented at addiction medicine conferences in 2024 and 2025, have reported that participants on semaglutide experienced fewer heavy drinking days, lower craving scores on validated assessment tools, and in some cohorts spontaneous reductions in other substance use that wasnt being directly targeted

Congeners can exacerbate hangover symptom severity 41

But it will take some time before it's completely out of the market, and we have a fair chance of regaining our fair share (of the market)." And yet, as of 2026, compounded GLP-1s dont appear to be going anywhere

Cytokine activation has been noted in ME/CFS patients (225) and appears to increase along with disease severity (231)